- April 5, 2023
- Posted by: AliensFaith
- Category: OBJECTIVE PRESS
No Comments
The availability of the drug in India may cause a major disruption in the Indian diabetes care drugs market which is expected to register a CAGR greater than 3.5 percent between 2022 and 2027. The COVID-19 pandemic has contributed a major increase in the market.